TickerFacts.

ADMA Biologics, Inc. (ADMA): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

237.87M
As of 2025-12-31
225.36M
As of 2026-06-30
+2.4%
3-year compound annual growth
+17.8%
5-year compound annual growth
+36.3%
10-year compound annual growth
2011-12-31: 408.6K2012-12-31: 5.87M2013-12-31: 9.29M2014-12-31: 9.29M2015-12-31: 10.71M2016-12-31: 12.89M2017-12-31: 36.73M2018-12-31: 46.35M2019-12-31: 59.32M2020-12-31: 104.90M2021-12-31: 195.81M2022-12-31: 221.82M2023-12-31: 226.06M2024-12-31: 236.62M2025-12-31: 237.87M237.87M
2011-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31237.87M+0.5%2026-02-25, Balance as of period end
2024-12-31236.62M+4.7%2026-02-25, Balance as of period end
2023-12-31226.06M+1.9%2025-03-18, Balance as of period end
2022-12-31221.82M+13.3%2024-02-28, Balance as of period end
2021-12-31195.81M+86.7%2023-03-23, Balance as of period end
2020-12-31104.90M+76.8%2022-03-24, Balance as of period end
2019-12-3159.32M+28.0%2021-03-25, Balance as of period end
2018-12-3146.35M+26.2%2020-03-13, Balance as of period end
2017-12-3136.73M+185.0%2019-03-13, Balance as of period end
2016-12-3112.89M+20.3%2018-03-29, Balance as of period end
2015-12-3110.71M+15.3%2017-02-24, Balance as of period end
2014-12-319.29M0.0%2016-03-23, Balance as of period end
2013-12-319.29M+58.3%2015-03-09, Balance as of period end
2012-12-315.87Mn/c2014-03-28, Balance as of period end
2011-12-31408.6Kn/a2013-03-06, Balance as of period end